天津医药 ›› 2026, Vol. 54 ›› Issue (10): 1018-1023.doi: 10.11958/20260411

• 实验研究 • 上一篇    下一篇

抗炎合剂通过TLR4/TRIF通路调节脓毒症急性肺损伤大鼠的肠道菌群

郑天虹(), 汪海慧△(), 金陟鸢   

  1. 上海市中医医院急诊与重症医学科 (邮编 200071)
  • 收稿日期:2026-02-05 修回日期:2026-04-08 出版日期:2026-10-15 发布日期:2026-10-10
  • 通讯作者: △E-mail:wanghaihui1982@126.com
  • 作者简介:郑天虹(1982),女,主治医师,主要从事重症感染方面研究。E-mail:joezth@126.com
  • 基金资助:
    上海市科学技术委员会资助项目(25010704000)

The anti-inflammatory preparation regulating the intestinal flora of rats with acute lung injury due to sepsis through the TLR4/TRIF pathway

ZHENG Tianhong(), WANG Haihui△(), JIN Zhiyuan   

  1. Department of Emergency and Critical Care Medicine, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, China
  • Received:2026-02-05 Revised:2026-04-08 Published:2026-10-15 Online:2026-10-10
  • Contact: △E-mail:wanghaihui1982@126.com

摘要:

目的 探讨抗炎合剂调控Toll样受体4(TLR4)/β干扰素TIR结构域衔接蛋白(TRIF)通路对脓毒症急性肺损伤(ALI)大鼠肠道菌群的影响。方法 将大鼠随机分为Sham组、脓毒症ALI组、抗炎合剂组(造模前3 d及造模后1 h灌胃14 g/kg抗炎合剂,每天1次)、坏死性凋亡抑制剂Necrostatin-1(Nec-1)组(造模前3 d及造模后1 h腹腔注射0.6 mg/kg Nec-1,每天1次),每组10只,脓毒症ALI组和Sham组灌胃等量生理盐水,每天1次。检测各组大鼠肺功能[用力肺活量(FVC)、0.3秒用力呼气容积(FEV0.3)、呼气峰值流速(PEF)];酶联免疫吸附试验检测血清中肿瘤坏死因子(TNF)-α、白细胞介素(IL)-1β、IL-6的表达;检测粪便肠道菌群;HE染色观察大鼠肺和小肠组织病理变化;Western blot检测肺和小肠组织中TLR4、TRIF蛋白的表达。结果 与Sham组比较,脓毒症ALI组可见肺泡明显萎缩,肺泡壁增厚,肺间质水肿,大量炎性细胞浸润,小肠绒毛缩短、脱落,隐窝结构变形,存在大量的炎性细胞浸润;肺功能下降(FVC、FEV0.3/FVC、PEF降低),血清中炎性因子TNF-α、IL-1β、IL-6表达升高,肠道菌群失衡(双歧杆菌、乳酸杆菌数量减少,大肠杆菌数量增多),肺和小肠组织中TLR4、TRIF蛋白高表达(P<0.05)。抗炎合剂组、Nec-1组肺和小肠组织损伤减轻,炎性细胞浸润减少,并可有效逆转脓毒症ALI组上述指标变化,且Nec-1组效果更好(P<0.05)。结论 抗炎合剂可以通过抑制TLR4/TRIF通路改善脓毒症ALI大鼠的肠道菌群分布。

关键词: 脓毒症, 急性肺损伤, Toll样受体4, 胃肠道微生物组, β干扰素TIR结构域衔接蛋白, 抗炎合剂

Abstract:

Objective To explore the effect of anti-inflammatory decoction on gut microbiota of rats with septic acute lung injury (ALI) by regulating the Toll like receptor 4 (TLR4)/TIR-domain-containing adaptor inducing interferon-β (TRIF) pathway. Methods Rats were stochastically separated into the sham group, the septic ALI group, the anti-inflammatory decoction group (intragastric administration of 14 g/kg anti-inflammatory decoction once a day for 3 days before modeling and within 1 hour after modeling) and the necrosis inhibition agent Necrostatin-1 (Nec-1) group (intraperitoneal injection of 0.6 mg/kg Nec-1 once a day for 3 days before modeling and within 1 hour after modeling), with 10 rats in each group. The septic ALI group and the sham group were given an equal amount of physiological saline by gavage once a day. The lung function of each group of rats [forced vital capacity (FVC), forced expiratory volume at 0.3 seconds (FEV0.3), peak expiratory flow rate (PEF)] were measured. ELISA was used to detect serum levels of TNF-α, IL-1β and IL-6. Fecal gut microbiota was detected. HE staining was used to detect pathological changes in rat lung tissue and small intestine tissue. Western blot assay was used to detect TLR4 and TRIF proteins in lung tissue and small intestine tissue. Results Compared with the sham group, obvious alveolar atrophy, thickening of the alveolar walls, pulmonary interstitial edema, extensive infiltration of inflammatory cells, shortening and detachment of intestinal villi, deformation of crypt structures and abundant infiltration of inflammatory cells were observed in the sepsis ALI group. It was also found that lung function declined (FVC, FEV0.3/FVC and PEF decreased), the serum expression levels of inflammatory factors TNF-α, IL-1β and IL-6 increased, intestinal flora imbalance (decreased counts of bifidobacterium and lactobacillus and increased counts of Escherichia coli) and the protein expressions of TLR4 and TRIF proteins in lung tissue and small intestine tissue increased (P<0.05). The anti-inflammatory agent group and Nec-1 group showed reduced lung and small intestine tissue damage, less inflammatory cell infiltration and effectively reversed the changes of the above indicators in the sepsis ALI group, and the Nec-1 group had a better effect (P<0.05). Conclusion Anti-inflammatory decoction can improve the distribution of gut microbiota in septic ALI rats by inhibiting TLR4/TRIF pathway.

Key words: sepsis, acute lung injury, Toll-like receptor 4, gastrointestinal microbiome, TIR-domain-containing adaptor inducing interferon-β, anti-inflammatory decoction

中图分类号: